Clinical Trial: Safety and Bioavailability of Micellar Green Tea Extract

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06971536) titled 'Safety and Bioavailability of Micellar Green Tea Extract' on May 06.

Brief Summary: This study seeks to determine the short-term effects of daily oral supplementation of LipoMicel Green Tea on oral absorption and safety of green tea in healthy volunteers.

The primary objective is to evaluate and compare the pharmacokinetics of LipoMicel Green Tea (LGT) with that of a standard green tea extract formulation as well as a phytosomal green tea formulation. The secondary objective is to evaluate the safety of LGT in healthy human participants over a 30-day study period.

Study Start Date: Dec. 10, 2023

Study Type: INTERVENTIONAL

Conditi...